Biointron Biological Inc Introduce
Exhibitor: OMICS BIOTECHNOLOGY CO.,LTD.
Date: 2025-05-22
Booth No.: L318
We specialize in antibody production and discovery – dedicating ourselves to advancing human health and promoting sustainability with more than 10 years of experience. We offer premium solutions at competitive rates, all anchored in our commitment to a brighter and healthier future.
Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, optimization, and expression services for global biotech and pharmaceutical companies. Biointron holds a leading position in the antibody expression industry. From gene sequence to purified antibodies, it only takes 2 weeks. We have delivered over ten thousand of recombinant antibodies for 2,000+ biotech and pharma companies worldwide.
We provide a one-stop solution for antibody discovery and optimization – including VHH antibody discovery, single B-cell antibody screening, hybridoma sequencing, antibody humanization, antibody affinity maturation, and more.
Additionally, Biointron holds global sublicensing rights for ECACC's CHO-K1. Our CHOK1BN cell line, which is derived from CHOK1, has been filed in the DMF system with the US FDA. By choosing the CHOK1BN cell line, several partners’ projects have entered the multicenter international clinical trials successfully.
Services We Offer
-
High-Throughput Recombinant Antibody Production
From sequences to antibodies, it happens in just 2 weeks.
-
Large Scale Recombinant Antibody Production
Scaling antibody solutions at speed: gram-levels to accomplish in just 4 weeks.
-
High Efficient Bispecific Antibody Production
Double the impact, half the time: we have successfully delivered thousands of bsAbs of customized formats.
-
Commercial Sublicense of CHOK1BN Cell
Line Licensed from ECACC, one-time sublicense fee for multiple products.
-
Unique binders guaranteed; self-owned alpaca breeding and farming base.
-
High-throughput Antibody Humanization
Back mutation and CDR grafting, affinity guaranteed.
-
Delivered in 1 week, with a guaranteed 100% sequence accuracy.
-
Catalog Products - Antibodies for in vivo Research
Research-grade target-positive antibodies, isotype-negative antibodies, anti-mouse antibodies, fusion proteins, and more.
More Exhibitor's Press Release
- VP-Motion is Japan’s leading AI-powered human behavior analysis software JYTC CO., LTD. / 2025-07-13
- Igus and JYTC walk together for better options. (German beer limited served daily) JYTC CO., LTD. / 2025-07-13
- Why choose Mecademic for robotic lab automation? JYTC CO., LTD. / 2025-07-13
- GoldenBiotech Seminar:Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 GOLDEN BIOTECHNOLOGY CORP. / 2025-07-12
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-07-11
- National Yang Ming Chiao Tung University’s Innovative Biotech and Medical Technologies NATIONAL YANG MING CHIAO TUNG UNIVERSITY / 2025-07-11
- Your Invitation to Innovation – Booth M412 Forum MAJOR SCIENCE CO.,LTD / 2025-07-09
- Cell Bio Biotechnology to Host Three International Authorities at BioAsia 2025, Unveiling a New Era CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-07-09
- Rooted in Mountains, Climbing the Peaks. BIOMEDICAL TRANSLATION RESEARCH CENTER, ACADEMIA SINICA (NATIONAL BIOTECHNOLOGY RESEARCH PARK) / 2025-07-09
- Honya’s MiSaver: A New Frontier in Treating Heart Damage After Heart Attacks HONYA MEDICAL CO., LTD. / 2025-07-08
- TaiMed Biologics Highlights Integrated CDMO Services at BIO Asia 2025 TAIMED BIOLOGICS INC. / 2025-07-08
- 現場校正、抽檢應用 攜帶式測量儀 XIN TOP CORPORATION / 2025-07-08
- 2025微脂體高值新藥開發 CDMO 產業說明會圓滿成功,業界專家共探創新契機 ZILLION FINE CHEMICAL INTERNATIONAL CO., LTD. / 2025-07-07
- 潤雅生技與日本精化簽署合作備忘錄(MOU) 攜手日隆精化,共拓CDMO業務版圖 ZILLION FINE CHEMICAL INTERNATIONAL CO., LTD. / 2025-07-07
- 日隆精化攜瑞采生技參訪日本精化 助推腎病高值新藥IND微脂體製備 ZILLION FINE CHEMICAL INTERNATIONAL CO., LTD. / 2025-07-07
- Latest Innovations! GeneFerm Collaborates with NTU to Launch: GFRena2, TestoPro, and AquaSoiivon GENEFERM BIOTECHNOLOGY CO., LTD. / 2025-07-07
- GeneFerm Strengthens Anaerobic and Precision Fermentation Capabilities to Advance as a Global-Standa GENEFERM BIOTECHNOLOGY CO., LTD. / 2025-07-07
- GeneFerm Biotechnology – Your Trusted CDMO Partner in Fermentation Technology GENEFERM BIOTECHNOLOGY CO., LTD. / 2025-07-07
- FDA Project Optimus-Impact and Response Strategy EFFICIENT PHARMA MANAGEMENT CORP. / 2025-07-07
- Seminar JAPAN FOOD RESEARCH LABORATORIES(JFRL) / 2025-07-04